Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Authors

Institutions

Publication Details

Journal
Neuropsychiatric Disease and Treatment
Published
2025-04-01
DOI
https://doi.org/10.2147/ndt.s503494
Citations
5
Primary Topic
Psychotherapy Techniques and Applications
Type
article
Field-Weighted Citation Impact
11.53

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Judith C. Kando, Leslie Citrome, Nichole M. Neugebauer‎, Alicia A Meli
5 citations
Neuropsychiatric Disease and Treatment
Psychotherapy Techniques and Applications
11.53
article

Xanomeline and Trospium Chloride Versus Placebo for the Treatment of Schizophrenia: A Post Hoc Analysis of Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed

Judith C. Kando, Leslie Citrome, Nichole M. Neugebauer‎, Alicia A Meli
article en
5 citations

Abstract

No abstract available for this paper.
Neuropsychiatric Disease and TreatmentVol. Volume 21
New York Medical College (US), Bristol-Myers Squibb (United States) (US)
Bristol-Myers Squibb
Openalex Percentile: Top 2%
Psychotherapy Techniques and Applications
11.53
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.